Argenx
ARGX
#567
Rank
ยฃ27.74 B
Marketcap
ยฃ454.87
Share price
-0.73%
Change (1 day)
45.87%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ2.60 Billion

According to Argenx 's latest financial reports the company has ยฃ2.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ2.69 B7.87%
2023-12-31ยฃ2.49 B37.72%
2022-12-31ยฃ1.81 B4.69%
2021-12-31ยฃ1.73 B-3.91%
2020-12-31ยฃ1.80 B40.53%
2019-12-31ยฃ1.28 B120.26%
2018-12-31ยฃ0.58 B51.89%
2017-12-31ยฃ0.38 B341.87%
2016-12-31ยฃ86.71 M153.98%
2015-12-31ยฃ34.14 M-35.78%
2014-12-31ยฃ53.16 M98.06%
2013-12-31ยฃ26.84 M50.5%
2012-12-31ยฃ17.83 M-30.04%
2011-12-31ยฃ25.49 M181.78%
2010-12-31ยฃ9.04 M